Studies Genes Behind Hormone and Metabolic Disorders in Children and Relatives
Looks at gene causes of hormone and metabolism disorders in children and relatives.
Key facts
- Who runs it
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Evaluation of Children With Endocrine and Metabolic-Related Conditions
- Status
- Recruiting
- People taking part
- 15,000 people, planned
- Started
- 12 Jul 2016
- Expected to end
- 31 Dec 2030
- Type of study
- Observational
- Record updated
- 21 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children with a known or suspected endocrine disorder. Relatives may also join if needed to help diagnose a child.
- Age
- Children with the disorder: 3 months to 18 years. Relatives: 3 months to 100 years.
- Sex
- Anyone can join, male or female.
- Disease stage
- A known or suspected endocrine or metabolic disorder.
Main reasons for not taking part
- No suspected endocrine disorder
- Medical, physical, psychiatric or social conditions that the investigators think make joining not in the patient's interest
- Being critically ill, unstable, or having severe organ failure that could limit the endocrine evaluation
The registry criteria, word for word
Show all 6 criteriaShow less
Who cannot take part
- Lack of suspected endocrine disorders
- Any medical, physical, psychiatric, or social conditions, which, in the opinion of the investigators, would make participation in this protocol not in the best interest of the patient, will exclude participation. Patients who are critically ill, unstable, or with severe organ failure that may affect/limit the endocrine evaluation and place unsustainable demands on Clinical Center or NICHD resources will be excluded
- An individual who meets any of the following criteria will be excluded from participation in this study:
Other criteria
- INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Participants with known or suspected endocrine disorder age 3 months-18 years are eligible for this protocol
- Relatives ages 3 months-100 years may be enrolled if clinically indicated for the diagnosis of a proband
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: Harinder D Raipuria, C.R.N.P.Taking people
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
Endocrine glands give off hormones. Researchers want to learn more about the disorders that affect these glands in children. These disorders might be caused by changes in genes. Genes contain DNA, which is the blueprint of how a cell works. Researchers want to identify the genes involved in endocrine and metabolic disorders. This might help develop new ways to diagnose and treat the disorders.
Objective:
To study the inheritance of endocrine or metabolism disorders.
Eligibility:
Children ages 3month-18 with known or suspected endocrine or metabolism disorders.
Family members ages 3months-100. They may participate in the DNA part of the study.
Design:
Participants will be screened with a review of their medical records. Their parents or guardians will allow the records to be released.
Participants will have a clinic visit. This may include a physical exam and medical history.
Parents or guardians will give their consent for the study. Participants may have tests, surgery, or other procedures to help diagnose or treat their condition. These could include:
Blood, urine, and saliva tests
Growth hormone test
Pituitary and adrenal function tests
Picture of chromosomes
Imaging tests. These may include X-ray, ultrasound, scans, or a skeletal survey.
Genetic tests
Sleep study
Medical photographs
If surgery is done, a tissue sample will be taken.
Participants may have follow-up visits for diagnosis and treatment.
Participating relatives will have one visit. This will include medical history and blood and saliva tests. The blood and saliva will be used for DNA testing.
The group in the trial
- Case Only
Children ages 3 months to 100 with known or suspected endocrine or metabolism disorders. Family members ages 3 months to 100. They may participate in the DNA part of the study
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of Children With Endocrine and Metabolic-Related Conditions
- Plain-language title
- Studies Genes Behind Hormone and Metabolic Disorders in Children and RelativesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 21 October 2026